China Life CFO Yuan Ying: Company's Solvency Capability Shows Year-over-Year Decline but Remains Controllable Overall

Deep News
Aug 28

On August 28, China Life Insurance Company Limited held its 2025 interim results presentation. Addressing questions regarding the company's potential plans for further debt issuance and capital supplementation, China Life CFO Yuan Ying noted that due to market interest rate fluctuations, the company's solvency capability has indeed experienced a certain degree of decline compared to the previous year, but this overall impact remains controllable. She pointed out that if all of the company's fixed-income assets were measured at fair value, both the core and comprehensive solvency adequacy ratios could be enhanced by over 50 percentage points.

Looking ahead, Yuan Ying stated that the company will continue to deepen the integrated management of asset-liability matching to enhance sustainable development resilience under the current interest rate volatility environment. Through long-term and steady value creation and improving long-term profitability, the company will continuously strengthen its internal capital generation and supplementation capabilities. The company will also monitor various external supplementation channels and implement multiple measures to enhance solvency capability. Should there be any further capital supplementation plans in the future, the company will share them with the market accordingly.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10